Patents by Inventor Monica Borgatti

Monica Borgatti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of angelicin and of its structural analogues for the treatment of thalassemia
    Patent number: 7572827
    Abstract: The use of angelicin and its structural analogues for the preparation of a medicament for the therapeutic treatment of beta-thalassaemia is described. A structural analogue which is particularly preferred for this purpose is bergapten.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: August 11, 2009
    Assignees: Universita' Degli Studi Di Ferrara, Associazione Veneta Per La Lotta Alla Talassemia
    Inventors: Nicoletta Bianchi, Monica Borgatti, Roberto Gambari, Ilaria Lampronti
  • Use of rapamycin and structural analogues thereof
    Patent number: 7541380
    Abstract: The use of rapamycin and its structural analogues for the preparation of a medicament for the therapeutic treatment of beta-thalassaemia is described.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: June 2, 2009
    Assignees: Universita' Degli Studi do Ferrara, Associazione Veneta per la Lotta Alla Talassemia
    Inventors: Nicoletta Bianchi, Monica Borgatti, Roberto Gambari, Carlo Mischiati
  • Novel Use of rapamycin and structural analogues thereof
    Publication number: 20060154950
    Abstract: The use of rapamycin and its structural analogues for the preparation of a medicament for the therapeutic treatment of beta-thalassaemia is described.
    Type: Application
    Filed: July 3, 2003
    Publication date: July 13, 2006
    Applicants: ITA' DEGLI STUDI DI FERRARA, ASSOCIAZIONE VENETA PER LA LOTTA ALLA TALASSEMIA
    Inventors: Nicoletta Bianchi, Monica Borgatti, Roberto Gambari, Carlo Mischiati
  • Use of angelicin and of its structural analogues for the treatment of thalassemia
    Publication number: 20060111433
    Abstract: The use of angelicin and its structural analogues for the preparation of a medicament for the therapeutic treatment of beta-thalassaemia is described. A structural analogue which is particularly preferred for this purpose is bergapten.
    Type: Application
    Filed: July 30, 2003
    Publication date: May 25, 2006
    Inventors: Nicoletta Bianchi, Monica Borgatti, Roberto Gambari, Ilaria Lampronti